Claire D. Eliasberg

Dr. Claire D. Eliasberg


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
JSJoo Y. Sunwoo
Joo Y. Sunwoo
CEClaire D. Eliasberg
Claire D. Eliasberg
CCCamila B. Carballo
Camila B. Carballo
SRScott A. Rodeo
Scott A. Rodeo

11 April 2021 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XZXueying Zhang
Xueying Zhang
CEClaire D. Eliasberg
Claire D. Eliasberg
SRScott A. Rodeo
Scott A. Rodeo

1 July 2018 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
AJAndrew R. Jensen
Andrew R. Jensen
BKBenjamin V. Kelley
Benjamin V. Kelley
GMGina M. Mosich
Gina M. Mosich
AAAllison Ariniello
Allison Ariniello
CEClaire D. Eliasberg
Claire D. Eliasberg
FPFrank A. Petrigliano
Frank A. Petrigliano
After massive tears, rotator cuff muscle often undergoes atrophy, fibrosis, and fatty degeneration. These changes can lead to high surgical failure rates and poor patient outcomes. The identity of the progenitor cells involved in these processes has not been fully elucidated. Platelet-derived growth factor receptor β (PDGFRβ) and platelet-derived growth factor receptor α (PDGFRα) have previously been recognized as markers of cells involved in muscle fibroadipogenesis. We hypothesized that PDGFRα expression identifies a fibroadipogenic subset of PDGFRβ+ progenitor cells that contribute to fibroadipogenesis of the rotator cuff. We created massive rotator cuff tears in a transgenic strain of mice that allows PDGFRβ+ cells to be tracked via green fluorescent protein (GFP) fluorescence. We then harvested rotator cuff muscle tissues at multiple time points postoperatively and analyzed them for the presence and localization of GFP+ PDGFRβ+ PDGFRα+ cells. We cultured, induced, and treated these cells with the molecular inhibitor CWHM-12 to assess fibrosis inhibition. GFP+ PDGFRβ+ PDGFRα+ cells were present in rotator cuff muscle tissue and, after massive tears, localized to fibrotic and adipogenic tissues. The frequency of PDGFRβ+ PDGFRα+ cells increased at 5 days after massive cuff tears and decreased to basal levels within 2 weeks. PDGFRβ+ PDGFRα+ cells were highly adipogenic and significantly more fibrogenic than PDGFRβ+ PDGFRα- cells in vitro and localized to adipogenic and fibrotic tissues in vivo. Treatment with CWHM-12 significantly decreased fibrogenesis from PDGFRβ+ PDGFRα+ cells. PDGFRβ+ PDGFRα+ cells directly contribute to fibrosis and fatty degeneration after massive rotator cuff tears in the mouse model. In addition, CWHM-12 treatment inhibits fibrogenesis from PDGFRβ+ PDGFRα+ cells in vitro. Clinically, perioperative PDGFRβ+ PDGFRα+ cell inhibition may limit rotator cuff tissue degeneration and, ultimately, improve surgical outcomes for massive rotator cuff tears.

23 December 2020 in Arthroscopy
Verified
Journal Article
Closed access
CEClaire D. Eliasberg
Claire D. Eliasberg
KHKyle J. Hancock
Kyle J. Hancock
ESErica Swartwout
Erica Swartwout
HRHugo Robichaud
Hugo Robichaud
ARAnil S. Ranawat
Anil S. Ranawat

16 April 2021 in Arthroscopy
Verified
Journal Article
Closed access
CEClaire D. Eliasberg
Claire D. Eliasberg
DNDaniel A. Nemirov
Daniel A. Nemirov
BMBert R. Mandelbaum
Bert R. Mandelbaum
APAndrew D. Pearle
Andrew D. Pearle
JTJohn M. Tokish
John M. Tokish
SRScott A. Rodeo
Scott A. Rodeo

12 January 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
LWLing Wu
Ling Wu
SZShu Zhang
Shu Zhang
RSRuzanna Shkhyan
Ruzanna Shkhyan
SLSiyoung Lee
Siyoung Lee
FGFrancesca Gullo
Francesca Gullo
DEDenis Evseenko
Denis Evseenko
Osteoarthritis is the most common form of arthritis, and pain relief with opioid-like drugs is a commonly used therapeutic for osteoarthritic patients. Recent studies published by our group showed that the kappa opioid receptor (KOR) is highly expressed during human development in joint-forming cells. However, the precise role of this receptor in the skeletal system remains elusive. The main aim of the current study was to investigate the role of KOR signaling in synovial and cartilaginous tissues in pathological conditions. Our data demonstrate that KOR null mice exhibit accelerated cartilage degeneration after injury when compared with WT mice. Activation of KOR signaling increased the expression of anabolic enzymes and inhibited cartilage catabolism and degeneration in response to proinflammatory cytokines such as TNF-α. In addition, selective KOR agonists increased joint lubrication via the activation of cAMP/CREB signaling in chondrocytes and synovial cells. Taken together, these results demonstrate direct effects of KOR agonists on cartilage and synovial cells and reveals a protective effect of KOR signaling against cartilage degeneration after injury. In addition to pain control, local administration of dynorphin or other KOR agonist represents an attractive therapeutic approach in patients with early stages of osteoarthritis.